These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11115510)

  • 1. Roles of NF-kappaB and 26 S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human nonsmall cell lung carcinoma.
    Tabata M; Tabata R; Grabowski DR; Bukowski RM; Ganapathi MK; Ganapathi R
    J Biol Chem; 2001 Mar; 276(11):8029-36. PubMed ID: 11115510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibition with bortezomib enhances activity of topoisomerase I-targeting drugs by NF-kappaB-independent mechanisms.
    Takigawa N; Vaziri SA; Grabowski DR; Chikamori K; Rybicki LR; Bukowski RM; Ganapathi MK; Ganapathi R; Mekhail T
    Anticancer Res; 2006; 26(3A):1869-76. PubMed ID: 16827119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappa B activation in topoisomerase I inhibitor-induced apoptotic cell death in human non-small cell lung cancer.
    Tabata M; Ganapathi R
    Ann N Y Acad Sci; 2000; 922():343-4. PubMed ID: 11193918
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of NF-kappaB and proteasome activity in tumors: can we improve the therapeutic potential of topoisomerase I and topoisomerase II poisons.
    Ganapathi R; Vaziri SA; Tabata M; Takigawa N; Grabowski DR; Bukowski RM; Ganapathi MK
    Curr Pharm Des; 2002; 8(22):1945-58. PubMed ID: 12171521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
    Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
    Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
    Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
    Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin enhances irinotecan-induced apoptosis in human non-small cell lung cancer cells by inhibition of proteasome activity.
    Park IH; Kim JY; Choi JY; Han JY
    Invest New Drugs; 2011 Oct; 29(5):883-90. PubMed ID: 20467885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of nuclear factor kappaB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells.
    Bottero V; Busuttil V; Loubat A; Magné N; Fischel JL; Milano G; Peyron JF
    Cancer Res; 2001 Nov; 61(21):7785-91. PubMed ID: 11691793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ATM protein is required for sustained activation of NF-kappaB following DNA damage.
    Piret B; Schoonbroodt S; Piette J
    Oncogene; 1999 Apr; 18(13):2261-71. PubMed ID: 10327072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S phase dependence and involvement of NF-kappaB activating kinase to NF-kappaB activation by camptothecin.
    Habraken Y; Piret B; Piette J
    Biochem Pharmacol; 2001 Sep; 62(5):603-16. PubMed ID: 11585057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase cleavage product lacking amino-terminus of IkappaBalpha sensitizes resistant cells to TNF-alpha and TRAIL-induced apoptosis.
    Kim KW; Kim BJ; Chung CW; Jo DG; Kim IK; Song YH; Kwon YK; Woo HN; Jung YK
    J Cell Biochem; 2002; 85(2):334-45. PubMed ID: 11948689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events.
    Huang TT; Wuerzberger-Davis SM; Seufzer BJ; Shumway SD; Kurama T; Boothman DA; Miyamoto S
    J Biol Chem; 2000 Mar; 275(13):9501-9. PubMed ID: 10734098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancer.
    Chien CM; Yang JC; Wu PH; Wu CY; Chen GY; Wu YC; Chou CK; Tseng CH; Chen YL; Wang LF; Chiu CC
    Phytomedicine; 2019 Feb; 54():109-119. PubMed ID: 30668360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
    Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
    Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
    Dai Y; Rahmani M; Grant S
    Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro.
    Milligan SA; Nopajaroonsri C
    Anticancer Res; 2001; 21(1A):39-44. PubMed ID: 11299767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular responses to topoisomerase I poisons. Exploiting synergy for improved radiotherapy.
    Miyamoto S; Huang TT; Wuerzberger-Davis S; Bornmann WG; Pink JJ; Tagliarino C; Kinsella TJ; Boothman DA
    Ann N Y Acad Sci; 2000; 922():274-92. PubMed ID: 11193903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells.
    Giuliano M; Lauricella M; Calvaruso G; Carabillò M; Emanuele S; Vento R; Tesoriere G
    Cancer Res; 1999 Nov; 59(21):5586-95. PubMed ID: 10554039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 signaling plays an important role in topoisomerase II poison-induced G2/M checkpoint activation.
    Kolb RH; Greer PM; Cao PT; Cowan KH; Yan Y
    PLoS One; 2012; 7(11):e50281. PubMed ID: 23166842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells.
    Chen MC; Pan SL; Shi Q; Xiao Z; Lee KH; Li TK; Teng CM
    Cancer Sci; 2012 Jan; 103(1):80-7. PubMed ID: 21920000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.